Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Cipla
Harvard Business School
Queensland Health
Citi

Generated: September 23, 2019

DrugPatentWatch Database Preview

Chloroquine phosphate - Generic Drug Details

  Try a free trial


See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for chloroquine phosphate and what is the scope of chloroquine phosphate freedom to operate?

Chloroquine phosphate is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Teva, and Watson Labs, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for chloroquine phosphate. Two suppliers are listed for this compound.

Pharmacology for chloroquine phosphate
Drug ClassAntimalarial
Synonyms for chloroquine phosphate
069C852
1,4-diamine bis(phosphate)
1,4-Pentanediamine, N(sup 4)-(7-chloro-4-quinolinyl)-N(sup 1),N(sup 1)-diethyl-, phosphate (1:2)
1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N',N'-diethyl-, (+-)-, phosphate (1:2)
1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, phosphate (1:2)
3377 RP
4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine; phosphoric acid
4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine;phosphoric acid
50-63-5
6384-82-3
69698-56-2
7-Chlor-4-(4-(diaethylamino)-1-methylbutylamino)-chinolindiphosphat
7-Chlor-4-(4-(diaethylamino)-1-methylbutylamino)-chinolindiphosphat [German]
7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline phosphate (1:2)
7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline phosphate
7-Chloro-4-[4-(diethylamino)-1-methylbutylamino]quinoline Diphosphate
7-CHLORO-N-[5-(DIETHYLAMINO)PENTAN-2-YL]QUINOLIN-4-AMINE; BIS(PHOSPHORIC ACID)
AC-12463
AC1L228G
AC1Q6RTA
AI3-14952
AK142896
AKOS004910410
Alermine
AN-24378
ANW-43957
Aralen (TN)
Aralen diphosphate
Aralen phosphate
Arechin
BC204679
bis(phosphoric acid); {4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
C 6628
C18H26ClN3
CAS-50-63-5
CCG-39643
CCRIS 1554
CHEMBL58510
Chingamin phosphate
Chingaminum
Chlorochin diphosphate
Chloroquin diphosphate
Chloroquindiphosphat
Chloroquine (diphosphate)
chloroquine bis(dihydrogenphosphate) dihydrate
Chloroquine bis(phosphate)
Chloroquine dihydrogen phosphate (1:2)
Chloroquine diphosphate
Chloroquine diphosphate salt
Chloroquine diphosphate salt, 98%
Chloroquine diphosphate salt, solid, >=98%
Chloroquine Diphosphate, Sulfate
Chloroquine diphosphate,(S)
Chloroquine phosphate (USP)
Chloroquine phosphate [USAN:BAN]
Chloroquine phosphate [USP:BAN]
Chloroquine phosphate, Pharmaceutical Secondary Standard; Certified Reference Material
Chloroquine phosphate, United States Pharmacopeia (USP) Reference Standard
Chloroquinediphosphate
CS-3811
CTK8B4126
D02125
Delagil
dl-Chloroquine diphosphate
DSSTox_CID_24681
DSSTox_GSID_44681
DSSTox_RID_80393
DTXSID7044681
EINECS 200-055-2
EU-0100296
F2173-1139
FT-0602804
Gontochin phosphate
H-Stadur
HMS1569N17
HMS1920O05
HMS2091C16
HMS2096N17
HMS3260L14
HMS3713N17
HMS501E06
HY-17589
Ipsen 225
Khingamin
khingamin phosphate
KS-00000RXN
LP00296
LS-141727
MCULE-4724842928
MFCD00069852
Miniquine
MolPort-003-665-488
N(4)-(7-Chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine, phosphate (1:2)
N4-(7-Chloro-4-quinolinyl)-N1,N1-dimethyl-1,4-pentanediamine diphosphate salt
N4-(7-Chloro-4-quinolyl)-N1,N1-diethyl-1,4-pentanediamine Diphosphate
N4-(7-chloro-4-quinolyl)-N1,N1-diethyl-pentane-1,4-diamine; phosphoric acid
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine bis(phosphate)
NCGC00015256-01
NCGC00015256-12
NCGC00093746-01
NCGC00093746-02
NCGC00093746-03
NCGC00260384-01
NCGC00260981-01
NE31607
NSC 14050
Prestwick_867
Quinoline, 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)-, phosphate (1:2)
Quinoline, 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)-, phosphate (1:2) (8CI)
Quinoline, 7-chloro-4-(4-diethylamino-1-methyl-butylamino)-, diphosphate
SCHEMBL40827
SN 7,618
SN 7618
SPECTRUM1500179
SR-01000075548
SR-01000075548-1
SR-01000075548-3
SR-01000075548-5
Tanakan
Tanakan (antimalarial)
Tanakene
Tox21_110115
Tox21_110115_1
Tox21_202838
Tox21_500296
unspecified phosphate of chloroquine diphosphate
WR 1522

US Patents and Regulatory Information for chloroquine phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 083082-001 Approved Prior to Jan 1, 1982 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 040516-001 Aug 29, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ipca Labs Ltd CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 090610-001 Dec 3, 2009 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 088030-001 Dec 21, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Md Pharm CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 087228-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Purepac Pharm CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 080886-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us ARALEN chloroquine phosphate TABLET;ORAL 006002-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Express Scripts
Argus Health
Moodys
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.